Multifactorial impact on the outcome of interval debulking surgery in patients with advanced epithelial ovarian or peritoneal cancers.


Journal

Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 29 12 2018
revised: 12 03 2019
accepted: 13 03 2019
pubmed: 20 3 2019
medline: 28 11 2019
entrez: 20 3 2019
Statut: ppublish

Résumé

To evaluate the impact of multiple clinical features upon the outcome of interval cytoreductive surgery and thus upon the survival in patients with advanced ovarian cancer and primary peritoneal carcinoma. A retrospective analysis of patients receiving NACT followed by IDS between 2009 and 2017. Patients were analyzed according to the pre-NACT CA125, pre-IDS CA125, pre-IDS CA125 decline, patients' pre-IDS BMI, multisite bowel involvement and different working years of surgeons, for their influence upon the IDS outcome (e.g. optimal vs suboptimal) and the survival. After interval debulking surgery following 1-6 cycles of NACT, all patients analyzed were identified as optimal (n = 113) and suboptimal (n = 47) based on patients' record. The PFS/OS were 21/68 months and 9/26 months in optimal and suboptimal groups, respectively (p = .000, p = .000). Although differential levels of pre-IDS CA125, pre-IDS CA125 decline, bowel involvement and surgeons' working years were found to be significantly different between the two groups, surgeons' working years and multisite bowel invasion were the independent factors for IDS outcome, and the latter one was also highly related to survival. Following NACT, the rate of optimal IDS might be improved for patients without multisite bowel involvement. For those with bowel involvement, management strategy made by well-experienced surgeons might be a key factor for the outcome of IDS.

Identifiants

pubmed: 30885671
pii: S0009-8981(19)31718-8
doi: 10.1016/j.cca.2019.03.1613
pii:
doi:

Substances chimiques

CA-125 Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-153

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Qing-Xiu Jiang (QX)

Department of Obstetrics & Gynecology, The First Affiliated Hospital of Chongqing Medical University, China.

Yu-Xia Jiang (YX)

Department of Gynecology, The People's Hospital of Shapingba District, Chongqing 400030, China.

Xuan Wang (X)

Department of Gynecology, Yantai Yuhuangding Hospital, Qingdao University School of Medicine, Yantai 264000, Shandong Province, China.

Shu-Juan Luo (SJ)

Department of Obstetrics & Gynecology, The First Affiliated Hospital of Chongqing Medical University, China; Department of Obstetrics & Gynecology, Maternal and Child Care Service Centre of Chongqing, Chongqing 400016, China.

Rong Zhou (R)

Department of Obstetrics & Gynecology, The First Affiliated Hospital of Chongqing Medical University, China.

Hua Linghu (H)

Department of Obstetrics & Gynecology, The First Affiliated Hospital of Chongqing Medical University, China. Electronic address: linghu_hua@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH